The early-year market rally lost its steam gradually owing to the inpouring of hotter-than-anticipated macroeconomic data. The Fed’s hawkish comments further aggravated the already existing investor anxieties.
Amid such uncertainties that are likely to persist in upcoming months, let us have a look at stable stocks Johnson & Johnson (JNJ) and Pfizer Inc. (PFE), which could help investors keep money in their pockets.
